A detailed history of Campbell & CO Investment Adviser LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 34,533 shares of BLFS stock, worth $962,089. This represents 0.07% of its overall portfolio holdings.

Number of Shares
34,533
Previous 13,256 160.51%
Holding current value
$962,089
Previous $285,000 208.77%
% of portfolio
0.07%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

BUY
$20.64 - $26.74 $439,157 - $568,946
21,277 Added 160.51%
34,533 $880,000
Q2 2025

Aug 07, 2025

BUY
$20.64 - $25.27 $273,603 - $334,979
13,256 New
13,256 $285,000
Q4 2023

Feb 13, 2024

BUY
$8.99 - $16.86 $131,973 - $247,504
14,680 New
14,680 $238,000
Q2 2022

Aug 09, 2022

SELL
$10.54 - $24.2 $151,554 - $347,971
-14,379 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$20.81 - $37.29 $299,226 - $536,192
14,379 New
14,379 $327,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.19B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.